INDOCO REMEDIES Announces Quarterly Results (2QFY20); Net Profit Up 194.1%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

INDOCO REMEDIES Announces Quarterly Results (2QFY20); Net Profit Up 194.1%
Tue, 5 Nov

INDOCO REMEDIES has announced its results for the quarter ended September 2019. Here is a detailed performance review of the same:

INDOCO REMEDIES Quarterly Financials

No. of Mths
Qtr. Ending
3
Sep-18*
3
Jun-19*
3
Sep-19*
QoQ ChangeYoY Change
Net SalesRs m2,3562,5272,92015.6%23.9%
Other incomeRs m366-9.4%75.8%
TurnoverRs m2,3602,5332,92615.5%24.0%
ExpensesRs m2,2382,2992,59813.0%16.1%
Gross profitRs m11822832141.3%172.1%
DepreciationRs m1771701806.2%2.2%
InterestRs m506154-12.3%7.2%
Profit before taxRs m-1053933225.0%
TaxRs m-27-1920
Profit after taxRs m-782273236.2%
Gross profit margin%5.09.011.0
Effective tax rate%26.0-678.621.3
Net profit margin%-3.30.92.5
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 23.9% on a year-on-year (YoY) basis. The expenses were up by 16.1% YoY during the same period.
  • The company's operating profit increased by 172.1% YoY during the quarter. Consequently, operating profit margins witnessed a growth and stood at 11.0% in 2QFY20 as against 5.0% in 2QFY19.
  • Depreciation charges increased by 2.2% and finance costs increased by 7.2% YoY, respectively.
  • Other income increased by 75.8% YoY during the quarter.
  • Net profit for the quarter increased by 194.1% YoY. Net profit margins during the quarter increased from -3.3% in 2QFY19 to 2.5% in 2QFY20.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 15.6% on a quarter-on-quarter (QoQ) basis. The expenses were up by 13.0% QoQ during the same period.
  • The company's operating profit increased by 41.3% QoQ during the quarter. Consequently, operating profit margins witnessed a growth and stood at 11.0% in 2QFY20 as against 9.0% in 1QFY19.
  • Net profit for the quarter increased by 236.2% QoQ, while net profit margins increased from 0.9% in 1QFY19 to 2.5% in 2QFY20.

To see how INDOCO REMEDIES has performed over the last eight quarters,please visit here.

Free Guide: Find the Next Crorepati Stock in this Futuristic Industry

INDOCO REMEDIES Share Price Performance

Over the last one year,INDOCO REMEDIES share price has moved down from Rs 184.6 to Rs 161.0, registering a Loss of Rs 23.6 or around 12.8%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 13,336.2 (up 0.1%). Over the last one year it has moved down from 14,469.9 to 13,336.2, a gain of 1,134 points (down 7.8%).

Overall, the S&P BSE SENSEX is up 15.4% over the year.

Current Valuations

At the current price of Rs 161.0, the price to earnings (P/E) ratio of INDOCO REMEDIES stands at 56.0 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 2.2 times.

Equitymaster requests your view! Post a comment on "INDOCO REMEDIES Announces Quarterly Results (2QFY20); Net Profit Up 194.1%". Click here!

  

Related Views on News

INDOCO REMEDIES Announces Quarterly Results (1QFY20); Net Profit Up 118.1% (Quarterly Result Update)

Aug 14, 2019 | Updated on Aug 14, 2019

For the quarter ended June 2019, INDOCO REMEDIES has posted a net profit of Rs 22 m (up 118.1% YoY). Sales on the other hand came in at Rs 3 bn (up 16.2% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

INDOCO REMEDIES Announces Quarterly Results (4QFY19); Net Profit Down 43.3% (Quarterly Result Update)

Jun 6, 2019 | Updated on Jun 6, 2019

For the quarter ended March 2019, INDOCO REMEDIES has posted a net profit of Rs 116 m (down 43.3% YoY). Sales on the other hand came in at Rs 3 bn (down 6.5% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

INDOCO REMEDIES 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of INDOCO REMEDIES for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of INDOCO REMEDIES. Also includes updates on the valuation of INDOCO REMEDIES.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

Use My Secret to Increase Your Trading Profits Today

Dec 10, 2019

What to do after every trade.

A Simple, 7-Step Checklist for Your Trading Success

Dec 4, 2019

What we can learn from one of the greatest traders to have ever lived.

Blue Chips Are Passe. Get into these Stocks for Outstanding Gains in 2020(Profit Hunter)

Dec 5, 2019

This corner of the market could provide more returns than blue chips in 2020.

Make the Most of the Smallcap Rebound with These Stocks(Profit Hunter)

Dec 3, 2019

Even amid a gloomy economic scenario, there are smallcaps that have grown earnings over last one and a half year and I believe these could be the strongest candidates for a smallcap rebound.

What Is the IPO Euphoria Signaling Us About the Markets?(The 5 Minute Wrapup)

Dec 2, 2019

2019 will be remembered as the year of great money-making IPOs...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

INDOCO REMEDIES SHARE PRICE


Dec 13, 2019 (Close)

TRACK INDOCO REMEDIES

  • Track your investment in INDOCO REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON INDOCO REMEDIES

INDOCO REMEDIES 5-YR ANALYSIS

COMPARE INDOCO REMEDIES WITH

MARKET STATS